Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a locally advanced or metastatic solid tumour (such as head and neck cancer, ovarian cancer, cervical cancer, glioblastoma, non-small cell lung cancer, anal cancer, or other solid tumour types), or people who have been diagnosed with high-grade pre-cancerous changes of the cervix (called CIN II or CIN III)
- People aged 18 years or older at the time of joining the study
- People who are currently being treated or monitored under standard medical care or as part of another clinical trial
- People whose general health and ability to carry out daily activities falls within an acceptable range, as assessed by their doctor using a standard scale (confirm with trial site)
- People who are willing and able to give informed consent before any study-related procedures take place, and who are able to follow the study requirements
- People who are covered by a social health insurance scheme in France
- People who are already participating in other clinical trials may still be considered
Who may not be able to join:
- People who have a known history of Hepatitis B, Hepatitis C, HIV, or Hanta virus
- People for whom taking blood samples would be medically unsuitable, including those with a haemoglobin level below 8g/dl (a measure of low red blood cell levels)
- People who are pregnant or currently breastfeeding
- People whose psychological, family, geographic, or social circumstances may, in the investigator's judgement, prevent them from giving informed consent or following the study procedures
- People who are under legal guardianship or whose freedom is restricted by an administrative or legal order
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +33 5 31 15 53 66
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of CD4 and CD8 T cells expressing PD-1
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.